These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29629950)

  • 1. A Survey of Somatic Mutations in 41 Genes in a Cohort of T-Cell Lymphomas Identifies Frequent Mutations in Genes Involved in Epigenetic Modification.
    Fernandez-Pol S; Ma L; Joshi RP; Arber DA
    Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):416-422. PubMed ID: 29629950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of the G17V RHOA mutation in angioimmunoblastic T-cell lymphoma and related lymphomas using quantitative allele-specific PCR.
    Nakamoto-Matsubara R; Sakata-Yanagimoto M; Enami T; Yoshida K; Yanagimoto S; Shiozawa Y; Nanmoku T; Satomi K; Muto H; Obara N; Kato T; Kurita N; Yokoyama Y; Izutsu K; Ota Y; Sanada M; Shimizu S; Komeno T; Sato Y; Ito T; Kitabayashi I; Takeuchi K; Nakamura N; Ogawa S; Chiba S
    PLoS One; 2014; 9(10):e109714. PubMed ID: 25310466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas.
    Palomero T; Couronné L; Khiabanian H; Kim MY; Ambesi-Impiombato A; Perez-Garcia A; Carpenter Z; Abate F; Allegretta M; Haydu JE; Jiang X; Lossos IS; Nicolas C; Balbin M; Bastard C; Bhagat G; Piris MA; Campo E; Bernard OA; Rabadan R; Ferrando AA
    Nat Genet; 2014 Feb; 46(2):166-70. PubMed ID: 24413734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RHOA G17V mutation in angioimmunoblastic T-cell lymphoma: A potential biomarker for cytological assessment.
    Lee PH; Weng SW; Liu TT; You HL; Liao CK; Wang MC; Huang WT
    Exp Mol Pathol; 2019 Oct; 110():104294. PubMed ID: 31394087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis.
    Attygalle AD; Dobson R; Chak PK; Vroobel KM; Wren D; Mugalaasi H; Morgan Y; Kaur M; Ahmad R; Chen Z; Naresh KN; Du MQ
    Histopathology; 2022 Apr; 80(5):847-858. PubMed ID: 35064935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell.
    Yao WQ; Wu F; Zhang W; Chuang SS; Thompson JS; Chen Z; Zhang SW; Clipson A; Wang M; Liu H; Bibawi H; Huang Y; Campos L; Grant JW; Wright P; Ei-Daly H; Rásó-Barnett L; Farkas L; Follows GA; Gao Z; Attygalle AD; Ashton-Key M; Liu W; Du MQ
    J Pathol; 2020 Mar; 250(3):346-357. PubMed ID: 31859368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic Analysis of Angioimmunoblastic T-cell Lymphoma With or Without RHOA G17V Mutation Using Formalin-fixed Paraffin-embedded Sections.
    Nagao R; Kikuti YY; Carreras J; Kikuchi T; Miyaoka M; Matsushita H; Kojima M; Ando K; Sakata-Yanagimoto M; Chiba S; Nakamura N
    Am J Surg Pathol; 2016 Aug; 40(8):1041-50. PubMed ID: 27158755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angioimmunoblastic T-cell Lymphomas With the RHOA p.Gly17Val Mutation Have Classic Clinical and Pathologic Features.
    Ondrejka SL; Grzywacz B; Bodo J; Makishima H; Polprasert C; Said JW; Przychodzen B; Maciejewski JP; Hsi ED
    Am J Surg Pathol; 2016 Mar; 40(3):335-41. PubMed ID: 26574844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of the circulating tumor DNAs in angioimmunoblastic T- cell lymphoma.
    Sakata-Yanagimoto M; Nakamoto-Matsubara R; Komori D; Nguyen TB; Hattori K; Nanmoku T; Kato T; Kurita N; Yokoyama Y; Obara N; Hasegawa Y; Shinagawa A; Chiba S
    Ann Hematol; 2017 Sep; 96(9):1471-1475. PubMed ID: 28634614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angioimmunoblastic T cell lymphoma: novel molecular insights by mutation profiling.
    Wang M; Zhang S; Chuang SS; Ashton-Key M; Ochoa E; Bolli N; Vassiliou G; Gao Z; Du MQ
    Oncotarget; 2017 Mar; 8(11):17763-17770. PubMed ID: 28148900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of the biologic and clinical significance of genetic mutations in angioimmunoblastic T-cell lymphoma.
    Fukumoto K; Nguyen TB; Chiba S; Sakata-Yanagimoto M
    Cancer Sci; 2018 Mar; 109(3):490-496. PubMed ID: 28889481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCL6 locus is hypermethylated in angioimmunoblastic T-cell lymphoma.
    Nishizawa S; Sakata-Yanagimoto M; Hattori K; Muto H; Nguyen T; Izutsu K; Yoshida K; Ogawa S; Nakamura N; Chiba S
    Int J Hematol; 2017 Apr; 105(4):465-469. PubMed ID: 27921272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients.
    de Pádua Covas Lage LA; Barreto GC; Culler HF; Cavalcante JB; de Oliveira Alves LB; Nardinelli L; Bendit I; Zerbini MCN; Rocha V; Pereira J
    Cancer Biomark; 2022; 35(2):179-191. PubMed ID: 36093687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal Hematopoiesis and Bone Marrow Infiltration in Patients With Follicular Helper T-Cell Lymphoma of Angioimmunoblastic Type.
    Harland L; Borgmann V; Otto F; Overkamp M; Bonzheim I; Fend F; Quintanilla-Martinez L; Nann D
    Mod Pathol; 2024 Jul; 37(7):100519. PubMed ID: 38777036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.
    Sakata-Yanagimoto M; Enami T; Yoshida K; Shiraishi Y; Ishii R; Miyake Y; Muto H; Tsuyama N; Sato-Otsubo A; Okuno Y; Sakata S; Kamada Y; Nakamoto-Matsubara R; Tran NB; Izutsu K; Sato Y; Ohta Y; Furuta J; Shimizu S; Komeno T; Sato Y; Ito T; Noguchi M; Noguchi E; Sanada M; Chiba K; Tanaka H; Suzukawa K; Nanmoku T; Hasegawa Y; Nureki O; Miyano S; Nakamura N; Takeuchi K; Ogawa S; Chiba S
    Nat Genet; 2014 Feb; 46(2):171-5. PubMed ID: 24413737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive analysis of RHOA mutation positive and negative angioimmunoblastic T-cell lymphomas by targeted deep sequencing, expression profiling and single cell digital image analysis.
    Butzmann A; Sridhar K; Jangam D; Kumar J; Sahoo MK; Shahmarvand N; Warnke R; Rangasamy E; Pinsky BA; Ohgami RS
    Int J Mol Med; 2020 Oct; 46(4):1466-1476. PubMed ID: 32945366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters.
    Lemonnier F; Couronné L; Parrens M; Jaïs JP; Travert M; Lamant L; Tournillac O; Rousset T; Fabiani B; Cairns RA; Mak T; Bastard C; Bernard OA; de Leval L; Gaulard P
    Blood; 2012 Aug; 120(7):1466-9. PubMed ID: 22760778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological Implications of RHOA Mutations in Angioimmunoblastic T-Cell Lymphoma: A Meta-analysis: RHOA mutations in AITL.
    Nguyen PN; Tran NTB; Nguyen TPX; Ngo TNM; Lai DV; Deel CD; Hassell LA; Vuong HG
    Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):431-438. PubMed ID: 33849798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Droplet digital polymerase chain reaction assay and peptide nucleic acid-locked nucleic acid clamp method for RHOA mutation detection in angioimmunoblastic T-cell lymphoma.
    Tanzima Nuhat S; Sakata-Yanagimoto M; Komori D; Hattori K; Suehara Y; Fukumoto K; Fujisawa M; Kusakabe M; Matsue K; Wakamatsu H; Shimadzu M; Chiba S
    Cancer Sci; 2018 May; 109(5):1682-1689. PubMed ID: 29493850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G17V RHOA: Genetic evidence of GTP-unbound RHOA playing a role in tumorigenesis in T cells.
    Chiba S; Enami T; Ogawa S; Sakata-Yanagimoto M
    Small GTPases; 2015; 6(2):100-3. PubMed ID: 26103434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.